Felsenstein, Matthäus http://orcid.org/0000-0003-3146-8717
Hillebrandt, Karl H.
Timmermann, Lea
Feist, Mathilde
Benzing, Christian
Schmelzle, Moritz
Pratschke, Johann
Malinka, Thomas
Funding for this research was provided by:
Berlin Institute of Health
Charité - Universitätsmedizin Berlin
Article History
Received: 8 June 2021
Accepted: 19 August 2021
First Online: 2 September 2021
Declarations
:
: Matthäus Felsenstein, Karl Hillebrandt, Mathilde Feist, Lea Timmermann and Christian Benzing have no conflict of interest or financial ties to disclose; Moritz Schmelzle: Merck Serono GmbH, Bayer AG, ERBE Elektromedizin GmbH, Amgen Inc., Johnson & Johnson Medical GmbH, Takeda Pharmaceutical Limited, Olympus K.K., Medtronic GmbH, Intuitive; Thomas Malinka: Intuitive; Johann Pratschke: Intuitive, Johnson & Johnson Medical GmbH.
: CARE study obtained IRB approval under E/A4/084/17.
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for publication of the images in Fig. InternalRef removed.